ITEMS IN AFP WITH KEYWORD:
Nov 1, 2000 Issue
Guidelines on Migraine: Part 3. Recommendations for Individual Drugs [Practice Guidelines]
The U.S. Headache Consortium guidelines on the pharmacologic management of acute migraine include recommendations for individual drugs. The headache consortium developed efficacy and safety profiles of each drug.
Oct 15, 2000 Issue
Guidelines on Migraine: Part 2. General Principles of Drug Therapy [Practice Guidelines]
The U.S. Headache Consortium guidelines on the pharmacologic management of acute migraine emphasize the need for physicians and patients to work together to decide how to treat acute attacks.
Guidelines on the use of computed tomography (CT) or magnetic resonance imaging (MRI) in patients presenting with migraine have been developed by the U.S. Headache Consortium.
Two new intranasal migraine medications, sumatriptan and dihydroergotamine mesylate, may offer specific advantages for patients who are seeking alternatives to various oral or parenteral migraine abortive therapies. Placebo-controlled clinical studies demonstrate that both intranasal forms are effec...